The study is mainly for patients with Crawford type I-V thoracoabdominal aortic aneurysms, and all subjects who passed the screening and signed the informed consent will be enrolled. Patients who meet all the inclusion criteria and don't meet the exclusion criteria will be implanted with thoracoabdominal aortic stent system.~Patients will be followed up at discharge, 1 month, 6 months, 12 months after the implantation.
A First in man study to evaluate the safety and efficacy of thoracoabdominal aortic stent system for endovascular treatment of thoracoabdominal aortic aneurysms.